Pilot targeted treatment of enlarged supratrochlear vein of the forehead with 1320 nm endovenous laser ablation.

Abstract

ObjectivesEnlarged forehead veins are common, with the supratrochlear vein being a frequent patient concern. Given the potential morbidity of sclerotherapy and phlebectomy, endovenous laser ablation (EVLA) may be a viable treatment option.MethodsWe present a patient with an enlarged right supratrochlear forehead vein treated with a single session of 1320 nm EVLA.ResultsClinical eradication was demonstrated at 3 months posttreatment with only self-limited edema and delayed ecchymosis.ConclusionsPilot preliminary evidence demonstrates that EVLA of the supratrochlear vein has a high benefit-to-risk ratio.